Nutricia, the manufacturer of Neocate Formula, maintains that the cases highlighted in the BONE study represent only a small segment of patients with unique conditions. However, in a statement to the Clarion Ledger, a spokesperson acknowledged that the company had assembled an expert panel and issued guidance to health care professionals about monitoring these patients. Nutricia is also introducing a new formulation of Neocate that contains more highly-soluble phosphate. You and your family may be entitled to compensation for medical bills and other damages if your child was prescribed Neocate Formula and was subsequently diagnosed with rickets, dangerously low phosphate levels or unexplained broken bones. To learn more, visit Bernstein Liebhard LLP's website or call the Firm directly at 800-511-5092.